55.1 F
Los Angeles
Saturday, December 28, 2024

BUSINESS

Koreans buy into worldwide Threads hype

Korea is buying into the worldwide hype for Threads, with the number of users in the country sharply increasing. The number of daily active users of...

Automative chips in spotlight as EV popularity booms

Electric vehicles' popularity will continue to boost demand and increase prices for automotive chips, as EVs are equipped with more chips than diesel cars. Market...

Draining chip demand encourages SK hynix to sell water facilities

SK hynix plans to sell off its water treatment facilities to secure an estimated 1 trillion won ($766 million) in the face of deteriorating...

Samsung’s quarterly profit dives to 14-year low on chip glut

Samsung Electronics is expected to post its worst quarterly operating profit in 14 years in April-June period as a chip glut continues amid sluggish...

LG Energy inks massive lithium supply deal

LG Energy Solution has signed a massive lithium supply deal with a Chilean company, the battery maker said Friday. With the signing of the agreement,...

Incentive deal puts LG’s Canada battery plant on track

A battery manufacturing joint venture between LG Energy Solution and Stellantis will receive state incentives from the Canadian government equivalent to what the U.S....

Five Guys serve up sizzling start to Korean foray

U.S. fast-food chain Five Guys has impressed on its Korean debut with its Seoul store ranking among its top four global locations during its...

K-pop stocks down as antitrust regulator launches probe into unfair practices

Shares of K-pop powerhouses are falling as Korea's antitrust agency launches an investigation into their gapjil, or abuse of power, over their subcontractors. As of...

Samsung Display sues China’s BOE for patent infringement

Samsung Display has sued China’s BOE over patent infringement of multiple technologies related to OLED (organic light-emitting diode) panels. Samsung Display’s first legal action against...

SK Biopharmaceuticals acquires majority share of U.S biotech firm

SK Biopharmaceuticals has acquired 60 percent of U.S. biotech company Proteovant Therapeutics for $47.5 million, the company said on Friday. Founded in 2020, Proteovant Therapeutics...